Company Profile for 22nd Century Group, Inc.
Founded in 1998, 22nd Century Limited, LLC (22nd Century) is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased through genetic engineering and breeding. The company owns or exclusively controls 98 issued patents in 79 countries where at least 75% of the world's smokers reside. 22nd Century is committed to developing and commercializing (i) the world's most effective and acceptable smoking cessation aid and (ii) for those smokers who refuse to quit smoking, consumer-acceptable modified risk tobacco products that reduce exposure to smoke toxins compared to conventional cigarettes. Through a merger on January 25, 2011, 22nd Century became a wholly-owned subsidiary of 22nd Century Group, Inc. Goodrich Tobacco Company is a subsidiary of 22nd Century.
Company: 22nd Century Group, Inc. Headquarters Address: Williamsville, New York Williamsville, NY 14221 Main Telephone: 716-270-1523 Website: www.xxiicentury.com/ Ticker/ISIN: XXII(OTCBB)/US90137F1030 Type of Organization: Public Industry: Biotechnology Earnings Release Dates: 1st Quarter: May 25, 2011 2nd Quarter: August 25, 2011 3rd Quarter: November 25, 2011 4th Quarter: March 15, 2012 Key Executives: CEO: Joseph Pandolfino President: Henry Sicignano III VP of R&D: Michael Moynihan CEO Contact: Joseph Pandolfino Phone: 716-270-1523 Email: firstname.lastname@example.org CFO Contact: C. Anthony Rider Phone: 716-270-1523 Email: email@example.com
Source: 22nd Century Group, Inc.
Released April 22, 2011